Novel acylated insulin analogue

The invention provides a novel acylated insulin analogue, and particularly provides a side chain compound capable of being used for preparing the acylated insulin analogue, the acylated insulin analogue, a pharmaceutical composition of the acylated insulin analogue, pharmaceutical application of the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ZHAN ZHIZHU, YANG ZILAN, JIANG YAN, ZHENG BAOYE, LIU QIUYAN, WANG HAIGANG, HU YANGLING, LI WENJIA, LEI DAN, LIN SHUSHAN, WANG XI
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ZHAN ZHIZHU
YANG ZILAN
JIANG YAN
ZHENG BAOYE
LIU QIUYAN
WANG HAIGANG
HU YANGLING
LI WENJIA
LEI DAN
LIN SHUSHAN
WANG XI
description The invention provides a novel acylated insulin analogue, and particularly provides a side chain compound capable of being used for preparing the acylated insulin analogue, the acylated insulin analogue, a pharmaceutical composition of the acylated insulin analogue, pharmaceutical application of the acylated insulin analogue, an administration method of the acylated insulin analogue and a preparation method of the acylated insulin analogue. The acylated insulin analogue disclosed by the invention can be used for treating diabetes mellitus, has the effect of serving as a weekly-acting preparation or a longer-acting insulin preparation, and can be used for treating once a week or at a lower frequency, so that the compliance of a diabetic patient is increased. 本发明提供了一种新型的酰化的胰岛素类似物,具体提供了一种可以用于制备酰化胰岛素类似物的侧链化合物、酰化胰岛素类似物及其药物组合物、制药用途、给药方法和制备方法。本发明的酰化胰岛素类似物可用于治疗糖尿病,具有作为周制剂或更长效的胰岛素制剂的作用,可一周一次或更低频率用于治疗,增加糖尿病患者的顺应性。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN115385843A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN115385843A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN115385843A3</originalsourceid><addsrcrecordid>eNrjZJD3yy9LzVFITK7MSSxJTVHIzCsuzcnMU0jMS8zJTy9N5WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hoamxhamFibGjsbEqAEAMlklCw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Novel acylated insulin analogue</title><source>esp@cenet</source><creator>ZHAN ZHIZHU ; YANG ZILAN ; JIANG YAN ; ZHENG BAOYE ; LIU QIUYAN ; WANG HAIGANG ; HU YANGLING ; LI WENJIA ; LEI DAN ; LIN SHUSHAN ; WANG XI</creator><creatorcontrib>ZHAN ZHIZHU ; YANG ZILAN ; JIANG YAN ; ZHENG BAOYE ; LIU QIUYAN ; WANG HAIGANG ; HU YANGLING ; LI WENJIA ; LEI DAN ; LIN SHUSHAN ; WANG XI</creatorcontrib><description>The invention provides a novel acylated insulin analogue, and particularly provides a side chain compound capable of being used for preparing the acylated insulin analogue, the acylated insulin analogue, a pharmaceutical composition of the acylated insulin analogue, pharmaceutical application of the acylated insulin analogue, an administration method of the acylated insulin analogue and a preparation method of the acylated insulin analogue. The acylated insulin analogue disclosed by the invention can be used for treating diabetes mellitus, has the effect of serving as a weekly-acting preparation or a longer-acting insulin preparation, and can be used for treating once a week or at a lower frequency, so that the compliance of a diabetic patient is increased. 本发明提供了一种新型的酰化的胰岛素类似物,具体提供了一种可以用于制备酰化胰岛素类似物的侧链化合物、酰化胰岛素类似物及其药物组合物、制药用途、给药方法和制备方法。本发明的酰化胰岛素类似物可用于治疗糖尿病,具有作为周制剂或更长效的胰岛素制剂的作用,可一周一次或更低频率用于治疗,增加糖尿病患者的顺应性。</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221125&amp;DB=EPODOC&amp;CC=CN&amp;NR=115385843A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221125&amp;DB=EPODOC&amp;CC=CN&amp;NR=115385843A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHAN ZHIZHU</creatorcontrib><creatorcontrib>YANG ZILAN</creatorcontrib><creatorcontrib>JIANG YAN</creatorcontrib><creatorcontrib>ZHENG BAOYE</creatorcontrib><creatorcontrib>LIU QIUYAN</creatorcontrib><creatorcontrib>WANG HAIGANG</creatorcontrib><creatorcontrib>HU YANGLING</creatorcontrib><creatorcontrib>LI WENJIA</creatorcontrib><creatorcontrib>LEI DAN</creatorcontrib><creatorcontrib>LIN SHUSHAN</creatorcontrib><creatorcontrib>WANG XI</creatorcontrib><title>Novel acylated insulin analogue</title><description>The invention provides a novel acylated insulin analogue, and particularly provides a side chain compound capable of being used for preparing the acylated insulin analogue, the acylated insulin analogue, a pharmaceutical composition of the acylated insulin analogue, pharmaceutical application of the acylated insulin analogue, an administration method of the acylated insulin analogue and a preparation method of the acylated insulin analogue. The acylated insulin analogue disclosed by the invention can be used for treating diabetes mellitus, has the effect of serving as a weekly-acting preparation or a longer-acting insulin preparation, and can be used for treating once a week or at a lower frequency, so that the compliance of a diabetic patient is increased. 本发明提供了一种新型的酰化的胰岛素类似物,具体提供了一种可以用于制备酰化胰岛素类似物的侧链化合物、酰化胰岛素类似物及其药物组合物、制药用途、给药方法和制备方法。本发明的酰化胰岛素类似物可用于治疗糖尿病,具有作为周制剂或更长效的胰岛素制剂的作用,可一周一次或更低频率用于治疗,增加糖尿病患者的顺应性。</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJD3yy9LzVFITK7MSSxJTVHIzCsuzcnMU0jMS8zJTy9N5WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hoamxhamFibGjsbEqAEAMlklCw</recordid><startdate>20221125</startdate><enddate>20221125</enddate><creator>ZHAN ZHIZHU</creator><creator>YANG ZILAN</creator><creator>JIANG YAN</creator><creator>ZHENG BAOYE</creator><creator>LIU QIUYAN</creator><creator>WANG HAIGANG</creator><creator>HU YANGLING</creator><creator>LI WENJIA</creator><creator>LEI DAN</creator><creator>LIN SHUSHAN</creator><creator>WANG XI</creator><scope>EVB</scope></search><sort><creationdate>20221125</creationdate><title>Novel acylated insulin analogue</title><author>ZHAN ZHIZHU ; YANG ZILAN ; JIANG YAN ; ZHENG BAOYE ; LIU QIUYAN ; WANG HAIGANG ; HU YANGLING ; LI WENJIA ; LEI DAN ; LIN SHUSHAN ; WANG XI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN115385843A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHAN ZHIZHU</creatorcontrib><creatorcontrib>YANG ZILAN</creatorcontrib><creatorcontrib>JIANG YAN</creatorcontrib><creatorcontrib>ZHENG BAOYE</creatorcontrib><creatorcontrib>LIU QIUYAN</creatorcontrib><creatorcontrib>WANG HAIGANG</creatorcontrib><creatorcontrib>HU YANGLING</creatorcontrib><creatorcontrib>LI WENJIA</creatorcontrib><creatorcontrib>LEI DAN</creatorcontrib><creatorcontrib>LIN SHUSHAN</creatorcontrib><creatorcontrib>WANG XI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHAN ZHIZHU</au><au>YANG ZILAN</au><au>JIANG YAN</au><au>ZHENG BAOYE</au><au>LIU QIUYAN</au><au>WANG HAIGANG</au><au>HU YANGLING</au><au>LI WENJIA</au><au>LEI DAN</au><au>LIN SHUSHAN</au><au>WANG XI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Novel acylated insulin analogue</title><date>2022-11-25</date><risdate>2022</risdate><abstract>The invention provides a novel acylated insulin analogue, and particularly provides a side chain compound capable of being used for preparing the acylated insulin analogue, the acylated insulin analogue, a pharmaceutical composition of the acylated insulin analogue, pharmaceutical application of the acylated insulin analogue, an administration method of the acylated insulin analogue and a preparation method of the acylated insulin analogue. The acylated insulin analogue disclosed by the invention can be used for treating diabetes mellitus, has the effect of serving as a weekly-acting preparation or a longer-acting insulin preparation, and can be used for treating once a week or at a lower frequency, so that the compliance of a diabetic patient is increased. 本发明提供了一种新型的酰化的胰岛素类似物,具体提供了一种可以用于制备酰化胰岛素类似物的侧链化合物、酰化胰岛素类似物及其药物组合物、制药用途、给药方法和制备方法。本发明的酰化胰岛素类似物可用于治疗糖尿病,具有作为周制剂或更长效的胰岛素制剂的作用,可一周一次或更低频率用于治疗,增加糖尿病患者的顺应性。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN115385843A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Novel acylated insulin analogue
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T07%3A22%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHAN%20ZHIZHU&rft.date=2022-11-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN115385843A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true